IVIVC Test Systems for DDU and APSD

Two factors have been identified as being critical to improving the clinical relevance of DDU testing and APSD measurement: realistic breathing profiles and realistic throat and nasal models.

MDIs/DPIs/ADIs
DDU and ASPD of Nebulisers
Nasal Products
MDIs/DPIs/ADIs
DDU and ASPD of Nebulisers
Nasal Products

Please select an option:

DDU APSD
Learn More

Please select an option:

DDU APSD
Learn More

Related Services

Training

Training

We offer a range of training courses, presentations and seminars covering a wide range of topics.

Find Out More
Training

Servicing

A comprehensive range of both in-house and on-site product servicing options are available

Find Out More
Training

Support

Our team of experienced technicians and engineers are on hand to help and advise

Find Out More

Related News & Resources

DUSA Shaker DTS 100i

The new DUSA Shaker™ DTS 100i from Copley: For faster, safer, more repeatable inhaler testing

8th February 2023; Nottingham, UK: The DUSA Shaker™ DTS 100i is a new semi-automation solution from Copley Scientific, the global leader in inhaler and…

Find Out More

Copley launches EnviroMate™, an efficient, benchtop environmental chamber for inhaler testing

14 September 2022; Nottingham, UK: EnviroMate™ is a benchtop environmental control chamber from Copley, the world’s leading manufacturer and supplier of inhaler testing equipment,…

Find Out More
We support the Taskforce plan for Lung Health

Copley Scientific joins the Industries Forum of the Taskforce for Lung Health

23 June 2021; Nottingham, UK: Copley Scientific has joined the Industries Forum of the Taskforce for Lung Health. The Taskforce is a collaboration of over…

Find Out More
Copley Inhaler Testing Product Updates 2021

Copley announces a major upgrade of the world’s ‘go to’ inhaler testing portfolio

01 March 2021, Nottingham, UK: Copley Scientific, the global leaders in inhaler testing equipment, is marking the company’s 75th anniversary with a significant upgrade…

Find Out More

New e-Training service from Copley for pharmaceutical testing

14 January 2021; Nottingham, UK: Copley Scientific is now delivering e-Training, offering customers across the globe remote access to expert tuition on in vitro…

Find Out More

Copley launches a new webinar series on inhaler testing

20 April 2020; Nottingham, UK: Copley Scientific will shortly begin the company’s inaugural series of technical webinars, offering valuable, easy to understand overviews on…

Find Out More

Improving clinical realism: Upgraded IVIVC testing systems from Copley Scientific

29th June 2018; Nottingham, UK: New products from Copley Scientific enhance its offering for improving IVIVCs for orally inhaled and nasal drug products (OINDPs)….

Find Out More

Advancing the science of OINDPs: Copley Scientific joins IPAC-RS

28 February 2018; Nottingham, UK: Copley Scientific, a global leader in the design and manufacture of inhaler testing equipment, is pleased to announce that…

Find Out More
Child and Adult Alberta Idealised Throats

New research demonstrates the ability of the Child Alberta Idealised Throat to deliver better IVIVRs

28 May 2015; Nottingham, UK: New experimental studies using the Child Alberta Idealised Throat (C-AIT) from Copley Scientific confirm that it provides data more…

Find Out More

Copley Scientific introduces improved test set-up for more representative inhaled product testing

5 August 2014; Nottingham, UK: The desire to gain a better understanding of how inhaled products perform in patients has highlighted the importance and…

Find Out More

Introducing the new Alberta Idealized Throats from Copley Scientific – closer IVIVC in inhaled product testing

1 December 2010; Nottingham, UK: The Alberta Idealized Throat is a new product from Copley Scientific designed to improve in vivo/in vitro correlation (IVIVC)…

Find Out More
The NGI enclosed in the NGI Cooler

More precise nebuliser testing as Copley Scientific launches NGI Cooler

29 April 2009; Nottingham, UK: The new NGI Cooler from Copley Scientific is a practical, easy to use system that improves the accuracy and…

Find Out More

Q&A: OINDPnews 2022

Reducing Inhaler Testing Variability Through Test Environment Control In this Q&A with OINDPnews, our CEO Mark Copley answers questions about the importance of the…

Find Out More

DDD 2021 Respiratory eBook Profile

Semi-Automating Inhaler Testing – A Good Idea, but Where to Start? Cascade impaction is a vital technique in the development and manufacture of orally…

Find Out More

PMPS Q&A (Samedan): April 2021

Putting Inhalers to the Test Anna Sipitanou has worked for Copley Scientific for four years, expanding her drug discovery and pharma science background. She…

Find Out More

Microbioz India: February 2021

A short Q&A with our CEO, Mark Copley, on inhaled product testing

Find Out More

Inhalation Article: December 2019

Optimizing the role of automation in variability reduction strategies for delivered dose uniformity (DDU) and aerodynamic particle size distribution (APSD) testing of inhaled drug…

Find Out More

Inhalation Article: April 2019

The regulatory landscape for OINDPs – the biggest shake-up in a generation?

Find Out More

Drug Development & Delivery Article: April 2018

Optimizing the Application of In Vitro Test Methods for the Demonstration of Bioequivalence in Orally Inhaled Products

Find Out More

PMPS Article (Samedan): February 2018

Demonstrating Bioequivalence of Orally Inhaled Products Safe and cost-effective treatments for respiratory diseases are facing a growing demand. The demonstration of bioequivalence within locally…

Find Out More

White Paper: February 2018

Optimising the application of in vitro test methods for the demonstration of BE in OIPs

Find Out More